Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP187 in mild to moderate psoriatic arthritis
2013-004176-35Phase 2Terminated
- Sponsor
- Skåne University Hospital
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in psoriatic arthritis (PsA) comparing FP187 with Placebo (2 arms). Primary endpoint: ACR20 response at Week 24. Started Jan 2014; status: terminated.
02
Drugs
FP187-V2B
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2013-004176-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004176-35.